Accelerating the commercialisation of a disruptive analytical technology which enables the biopharmaceutical industry to manufacture drugs faster, cheaper and with greater regulatory confidence

Información del proyecto

BIOSIM

Identificador del acuerdo de subvención: 778586

DOI 10.3030/778586

Proyecto cerrado

Fecha de la firma de la CE 19 Septiembre 2017

Fecha de inicio 1 Octubre 2017

Fecha de finalización 31 Mayo 2019

Financiado con arreglo a

• SOCIETAL CHALLENGES - Health, demographic change and well-being

Coste total € 2 029 325,00

Aportación de la UE € 2 029 325,00

Coordinado por

VALITACELL LTD
Ireland

Resultado final

Demonstrators, pilots, prototypes (3)

CE marked product

Ensuring that Valitacell product and associated has the required CE registration

Peer reviewed publication submitted

Submission of results and outline of applicability and benefits of technology in a report to be published in a peer reviewed journal or online publication

Results exchanged

Review of the results from the four sites and analysis of same in order to determine the final model to be adopted in the product

Publicaciones

Peer reviewed articles (1)

High-throughput quantitation of Fc-containing recombinant proteins in cell culture supernatant by fluorescence polarization spectroscopy

Autores: Ben Thompson, Jerry Clifford, Mike Jenns, Andrew Smith, Ray Field, Kalpana Nayyar, David C. James
Publicado en: Analytical Biochemistry, Edición 534, 2017, Página(s) 49-55, ISSN 0003-2697
Editor: Academic Press
DOI: 10.1016/j.ab.2017.07.013

Derechos de propiedad intelectual

Patent (4)

A METHOD OF MEASURING ANTIBODY CONCENTRATION IN A SAMPLE

Número de solicitud/publicación: EP 15736411
Fecha: 2015-06-18
Solicitante(s): VALITACELL LTD

A METHOD OF PREDICTING PHENOTYPIC INSTABILITY IN A CELL

Número de solicitud/publicación: EP 15718799
Fecha: 2015-04-02
Solicitante(s): VALITACELL LTD

A METHOD OF MEASURING ANTIBODY CONCENTRATION IN A SAMPLE

Número de solicitud/publicación: EP 15736411
Fecha: 2015-06-18
Solicitante(s): VALITACELL LTD

A METHOD OF PREDICTING PHENOTYPIC INSTABILITY IN A CELL

Número de solicitud/publicación: EP 15718799
Fecha: 2015-04-02
Solicitante(s): VALITACELL LTD

Trademark (2)

chemstress

Número de solicitud/publicación: TM 017262511
Fecha: 2018-02-12
Solicitante(s): VALITACELL LTD

chemstress

Número de solicitud/publicación: TM 017262511
Fecha: 2018-02-12
Solicitante(s): VALITACELL LTD

Other (2)

A METHOD OF PREDICTING RELATIVE FED BATCH PRODUCTION TITER OF A PANEL OF CLONALLY-DERIVED PRODUCER CELLS

Número de solicitud/publicación: EP 14830805
Fecha: 2014-12-17
Solicitante(s): VALITACELL LTD

A METHOD OF PREDICTING RELATIVE FED BATCH PRODUCTION TITER OF A PANEL OF CLONALLY-DERIVED PRODUCER CELLS

Número de solicitud/publicación: EP 14830805
Fecha: 2014-12-17
Solicitante(s): VALITACELL LTD